4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-032867
Director sold 8,000 shares at $19.34 ($154,720)
- Director acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CHESS ROBERT · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-12 | Exercise or conversion : show line 1 in the form | +8,000 | $13.80 | $110,400 | 288,573 | D |
| 2021-05-12 | Sale : show line 2 in the form | −8,000 | $19.34 | $154,720 | 280,573 | D |
| Open-market sales · 8,000 sh · avg $19.34 · $154,720 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-12 | Exercise or conversion : show line 3 in the form Stock Option | −8,000 | 24,000 | D |
Loading xslF345X03/doc4.xml…